This $2,260,121 Project Grant was awarded on September 30, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant supports a study by General Dynamics Information Technology, Inc. (GDIT) to evaluate the use of remotely supervised transcranial direct current stimulation (tDCS) combined with cognitive training to improve complex attention in active-duty service members and veterans with mild traumatic brain injury. GDIT, a...
This federal Project Grant award of $2,217,454.00, awarded by the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420), supports a research study on the effects of transcranial photobiomodulation (PBM) in older adults with traumatic brain injury. The primary awardee is the Research Foundation of the City University of New York, which is collaborating with New York University School of Medicine as a sub-grantee. The research aims to...
This Project Grant award of $541,658.00 from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports targeted auditory plasticity training to improve central hearing in mild traumatic brain injury (TBI). The primary awardee is The University of Texas at San Antonio (UTSA), a Hispanic-serving research university. UTSA will collaborate with Northeastern University on this project, which involves customizing an auditory...
This $691,213 Project Grant from the Department of the Army Medical Command, under the Military Medical Research and Development program (CFDA 12.420), supports research into bioengineered 3D human brain systems to investigate risk factors, mechanisms, and treatments for traumatic brain injury-induced Alzheimer's disease. Tufts University is the primary awardee and will conduct research. Massachusetts General Hospital will provide $691,213 in research services as a sub-awardee. The overarching...
The federal Project Grant award of $810,000.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research on "EARLY NEUROMODULATION FOR COGNITIVE RECOVERY AND REHABILITATION IN TRAUMATIC BRAIN INJURY" at the University of Cincinnati. The grant, awarded on Nov 1, 2024, with a completion date of Oct 31, 2027, will fund scientific investigations exploring innovative approaches to disease prevention, diagnosis, treatment,...
This $2,169,063 federal Project Grant award from the Department of the Army Medical Command (CFDA 12.420 - Military Medical Research and Development) supports research on the safety and efficacy of thalamic-focused ultrasound stimulation for promoting recovery after severe traumatic brain injury. The primary awardee, the University of California, Los Angeles (UCLA), will lead the research effort, which includes establishing short-term efficacy, dose-related safety, and biomarkers of this...
The Department of the Army Medical Command awarded a $197,342 Project Grant to the RU School of Osteopathic Medicine through the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through August 2025 to investigate the effects of psychostimulants on cognitive flexibility and risk-based decision-making behavior following repetitive mild traumatic brain injury. The Military Medical Research and Development program supports basic,...
The Department of the Army Medical Command awarded a $1,302,658 Project Grant to the RU School of Osteopathic Medicine through the Military Medical Research and Development program. This three-year award will fund research into the effects of psychostimulants on cognitive flexibility and risk-based decision-making behavior following repetitive mild traumatic brain injury. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research aimed at...
This $737,899 federal Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program will fund the development and evaluation of a nontrauma intervention to treat post-traumatic stress disorder (PTSD) in veterans and service members suffering from traumatic brain injury (TBI). The University of Texas Health Science Center at San Antonio, a state-controlled institution of higher learning, will lead the research effort over a 3-year...
The University of Arizona, through the Arizona Board of Regents, was awarded a $3,004,651 Project Grant from the Defense Health Agency to develop a treatment for neuropsychological and memory impairments following moderate to severe traumatic brain injury. This grant, awarded under the Military Medical Research and Development (CFDA 12.420) program, funds a research project aimed at advancing scientific understanding and improving patient care for service members and veterans affected by...